Kevin Tan
Chief Financial Officer
Replay available
Selecta Biosciences, Inc. (SELB) Q2 2022 Earnings Call
Selecta Biosciences, Inc. (NASDAQ: SELB) Q2 2022 earnings conference call, held 2022-08-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Carson Bruhn
President and Chief Executive Officer
Peter Traber
Chief Medical Officer
Kei Kishimoto
Chief Scientific Officer
Kristin Kluska
Analyst, Cantor Fitzgerald
Yun Zong
Analyst, BTIG
Yatin Suneja
Analyst, Guggenheim Partners
John Newman
Analyst, Canaccord
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cartesian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.069 -- 00:00:04.971 And welcome to the Selecta Bio second quarter 2022 00:00:04.971 -- 00:00:07.613 earnings release conference call. 00:00:07.613 -- 00:00:10.654 All participants will be in listen-only mode. 00:00:10.654 -- 00:00:15.336 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.336 -- 00:00:17.858 key followed by zero. 00:00:17.858 -- 00:00:22.760 After today's presentation, there will be an opportunity to ask questions. 00:00:22.760 -- 00:00:28.182 To ask a question, you may press star, then one on a touch tone phone. 00:00:28.182 -- 00:00:32.575 To withdraw your question, please press star, then two. 00:00:32.575 -- 00:00:36.258 Please note, this event is being recorded. 00:00:36.258 -- 00:00:41.543 I would now like to turn the conference over to Kevin Tan, Chief Financial Officer 00:00:41.543 -- 00:00:45.164 of Selecta Bio. Please go ahead. 00:00:45.286 -- 00:00:49.490 Thank you and good morning. Welcome to our second quarter 2022 financial 00:00:49.490 -- 00:00:52.832 results and corporate update conference call. 00:00:52.832 -- 00:00:55.775 Press relief reporting our financial results is available in the investors and media 00:00:55.775 -- 00:00:59.847 section of Selecta's website, worldwidewebselectedbio.com, 00:01:00.689 -- 00:01:05.613 and our quarterly report on Form 10-Q for the quarter ended June 30th, 2022, which we 00:01:05.613 -- 00:01:10.898 intend to file in the coming days with the Securities and Exchange Commission, or SEC. 00:01:10.898 -- 00:01:15.721 Joining me today are Carson Bruhn, President and Chief Executive Officer, Peter Traber, 00:01:15.721 -- 00:01:20.886 Chief Medical Officer, and Kei Kishimoto, Chief Scientific Officer. 00:01:20.886 -- 00:01:24.789 During today's ca...